Clinical Trial Update: Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating traditional Chinese medicine combined with entecavir for refractory liver fibrosis in hepatitis B-related cirrhosis; status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis Virus-related Cirrhosis

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Traditional Chinese Medicine

Snippet

Sponsor: ShuGuang Hospital | Conditions: Hepatitis B Virus Related Cirrhosis | Phase 4 | Status: UNKNOWN